|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 152.35 ZAR | +3.09% |
|
+2.90% | +30.45% |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic after Novo patent expiry | RE |
| 07-20 | Aspen Pharmacare wins Canada approval for generic Ozempic injection | RE |
| Market Cap | 67.65B 4.14B 3.59B 3.36B 3.08B 5.81B 394B 5.88B 39.35B 15.44B 197B 15.54B 15.2B 656B | P/E 2026 * |
15.5x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 93.04B 5.69B 4.94B 4.63B 4.23B 7.99B 542B 8.09B 54.11B 21.24B 271B 21.37B 20.91B 902B | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 1.7x |
| Free-Float |
59.64% | Yield 2026 * |
1.75% | Yield 2027 * | 1.65% |
Last Transcript: Aspen Pharmacare Holdings Limited
| 1 day | +3.09% | ||
| 1 week | +2.90% | ||
| Current month | +2.18% | ||
| 1 month | -2.65% | ||
| 3 months | +1.93% | ||
| 6 months | +36.96% | ||
| Current year | +30.45% |
| 1 week | 145 |  | 153.18 |
| 1 month | 142.6 | | 158.55 |
| Current year | 104.38 | | 160.79 |
| 1 year | 90.7 | | 160.79 |
| 3 years | 90.7 | | 252.96 |
| 5 years | 90.7 | | 281.67 |
| 10 years | 64.07 | | 383.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Saad
CEO | Chief Executive Officer | 62 | 1996-12-31 |
Sean Capazorio
DFI | Director of Finance/CFO | 61 | 2008-12-31 |
| Chief Operating Officer | 63 | 1998-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Saad
BRD | Director/Board Member | 62 | 1998-12-31 |
| Director/Board Member | 65 | 1998-12-31 | |
Kuseni Dlamini
CHM | Chairman | 58 | 2015-12-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/23 | Free | Chief Operating Officer | 12,236 | 0.0027% | ||
| 9/27/23 | Free | Executive/Senior Manager | 11,728 | 0.0026% | ||
| 9/27/23 | Free | Founder | 10,558 | 0.0024% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.09% | +2.90% | +35.49% | -21.05% | 4.14B | |
| -0.52% | -2.46% | +21.47% | +67.26% | 49.14B | |
| +4.48% | +14.55% | +66.45% | +142.79% | 40.36B | |
| -0.37% | -0.10% | -1.29% | +20.28% | 12.53B | |
| -0.58% | -2.21% | +16.67% | +68.18% | 11.6B | |
| +1.53% | -0.57% | +33.08% | +134.53% | 9.07B | |
| -0.25% | +2.90% | +18.08% | +35.50% | 6.97B | |
| +1.97% | -0.06% | +39.98% | -12.54% | 6.94B | |
| +0.04% | +1.64% | +10.07% | +178.26% | 6.72B | |
| -1.46% | +2.11% | -30.64% | +14.13% | 5.59B | |
| Average | +0.79% | +2.19% | +20.94% | +62.73% | 15.31B | |
| Weighted average by Cap. | +1.15% | +3.42% | +30.45% | +82.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.62B 2.3B 2B 1.87B 1.71B 3.23B 219B 3.27B 21.88B 8.59B 110B 8.64B 8.45B 365B | 38.86B 2.38B 2.06B 1.93B 1.77B 3.34B 226B 3.38B 22.6B 8.87B 113B 8.93B 8.73B 377B |
| Net income | 4.8B 294M 255M 239M 218M 412M 27.96B 417M 2.79B 1.1B 13.97B 1.1B 1.08B 46.5B | 5B 306M 265M 248M 227M 429M 29.11B 434M 2.91B 1.14B 14.55B 1.15B 1.12B 48.42B |
| Net Debt | 25.39B 1.55B 1.35B 1.26B 1.15B 2.18B 148B 2.21B 14.77B 5.8B 73.93B 5.83B 5.71B 246B | -1.74B -106M -92.13M -86.27M -78.91M -149M -10.11B -151M -1.01B -396M -5.05B -399M -390M -16.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-06 | ZAR 152.35 | +3.09% | 1,301,229 |
| 26-08-05 | ZAR 147.78 | -0.09% | 549,573 |
| 26-08-04 | ZAR 147.92 | +0.82% | 1,107,536 |
| 26-08-03 | ZAR 146.71 | -1.60% | 958,670 |
| 26-07-31 | ZAR 149.10 | +0.70% | 1,356,484 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- APN Stock
Select your edition
All financial news and data tailored to specific country editions
